Advertisement

Use of Buffy Coat miRNA Profiling for Breast Cancer Prediction in Healthy Women

  • Sara Donzelli
  • Giovanni Blandino
  • Paola MutiEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1379)

Abstract

MicroRNAs are key regulators of different biological processes and their deregulation is associated with the occurrence of many diseases among which cancer. Due to the higher stability of microRNAs and to the easiness in their detection both in organs than in biological fluids, many studies are turned toward potential use of this small molecules as biomarkers for the prediction and diagnosis of different types of cancer. Here we describe the experiment protocol that we have used for microRNA profiling analysis in buffy coat samples of women who developed breast cancer versus women who remained healthy during a 20 year follow-up period, with the aim to identify predictive microRNAs of breast cancer occurrence.

Key words

microRNA microRNA profiling Buffy coat Breast cancer RNA extraction 

Notes

Acknowledgment

We are indebted to the 10,786 ORDET participants. We also thank Dr. Paolo Contiero and the staff of the Lombardy Cancer Registry for technical assistance. This work was supported by Department of Defense grant W81 XWH 04 1 0195 and by the Veronesi Foundation.

References

  1. 1.
    Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866CrossRefPubMedGoogle Scholar
  2. 2.
    Martello G, Rosato A, Ferrari F et al (2010) A MicroRNA targeting dicer for metastasis control. Cell 141:1195–1207CrossRefPubMedGoogle Scholar
  3. 3.
    Biagioni F, Bossel Ben-Moshe N, Fontemaggi G et al (2012) miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO Mol Med 4:1214–1229PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Cioce M, Ganci F, Canu V et al (2014) Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Oncogene 33:5319PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Kent OA, Mendell JT (2006) A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25:6188–6196CrossRefPubMedGoogle Scholar
  6. 6.
    Blandino G, Fazi F, Donzelli S et al (2014) Tumor suppressor microRNAs: a novel non-coding alliance against cancer. FEBS Lett 588:2639–2652CrossRefPubMedGoogle Scholar
  7. 7.
    Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259–269CrossRefPubMedGoogle Scholar
  8. 8.
    Calin GA, Croce CM (2006) MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25:6202–6210CrossRefPubMedGoogle Scholar
  9. 9.
    Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838CrossRefPubMedGoogle Scholar
  10. 10.
    Calin GA, Ferracin M, Cimmino A et al (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793–1801CrossRefPubMedGoogle Scholar
  11. 11.
    Chen PS, Su JL, Hung MC (2012) Dysregulation of microRNAs in cancer. J Biomed Sci 19:90PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Jung M, Schaefer A, Steiner I et al (2010) Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 56:998–1006CrossRefPubMedGoogle Scholar
  13. 13.
    Mraz M, Malinova K, Mayer J et al (2009) MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun 390:1–4CrossRefPubMedGoogle Scholar
  14. 14.
    Muti P, Pisani P, Crosignani P et al (1988) ORDET--prospective study on hormones, diet and breast cancer: feasibility studies and long-term quality control. Steroids 52:395–396CrossRefPubMedGoogle Scholar
  15. 15.
    Muti P, Sacconi A, Hossain A et al (2014) Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: the ORDET prospective study. Cancer Epidemiol Biomarkers Prev 23:2471–2481CrossRefPubMedGoogle Scholar
  16. 16.
    Chomczynski P, Sacchi N (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1:581–58517Google Scholar
  17. 17.
    Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B. Methodological, 57:289–300Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Translational Oncogenomics UnitRegina Elena Italian National Cancer InstituteRomeItaly
  2. 2.Laboratory of Translational Oncogenomics, Molecular Medicine DepartmentRegina Elena National Cancer InstituteRomeItaly
  3. 3.Department of Oncology, Faculty of Health ScienceMcMaster UniversityHamiltonCanada

Personalised recommendations